"There's always going to be set backs with a company like this" , agreed but we are more or less looking at snatching defeat from the jaws of victory as far as Hernia is concerned. Regarding Syntrel it is hard to fathom how, after successfully conducting a 10-patient feasibility study, the trial hit a snag after 25 patients, requiring no less than a 9-month protocol review (and counting) .....
Getting disillusioned, page-81
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.050(2.02%) |
Mkt cap ! $1.671B | |||
| Open | High | Low | Value | Volume |
| $2.48 | $2.52 | $2.40 | $3.338M | 1.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 70013 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 2062 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |